Free Hospital Medicine CME

Reversal of Novel Oral Anticoagulants (NOACs) discusses the problem of reversibility of NOACs and the development of new drugs which can accomplish this reversal.

By the end of Reversal of Novel Oral Anticoagulants (NOACs), you will be able to:
• Describe the pharmacodynamics and pharmacokinetics of novel oral anticoagulants (NOACs) with a focus on aspects that impact the reversibility of the drugs
• Identify the indications for administration of NOAC antidotes or reversal agents, and describe situations in which laboratory testing for coagulation is appropriate
• Apply NOAC reversal agents to patient cases taking the patient history and clinical presentation into account
• Describe the mechanisms of action of novel oral anticoagulants and their reversal agents, including universal and class- or drug-specific reversal agents

Target Audience:
Cardiologists, trauma surgeons, emergency medicine specialists, intensivists, internists; physician assistants, nurse practitioners, nurses, and pharmacists who practice in anticoagulation, emergency medicine, or critical care; and any other healthcare professionals who clinically encounter patients taking NOACs